138 related articles for article (PubMed ID: 33050940)
1. Patient reported outcome measures in a large cohort of patients with type 1 Gaucher disease.
Dinur T; Istaiti M; Frydman D; Becker-Cohen M; Szer J; Zimran A; Revel-Vilk S
Orphanet J Rare Dis; 2020 Oct; 15(1):284. PubMed ID: 33050940
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of Gaucher disease type 1 (GD1)-specific patient-reported outcome measures (PROMs) for clinical monitoring and for clinical trials.
Elstein D; Belmatoug N; Deegan P; Göker-Alpan Ö; Hughes DA; Schwartz IVD; Weinreb N; Bonner N; Panter C; Fountain D; Lenny A; Longworth L; Miller R; Shah K; Schenk J; Sen R; Zimran A
Orphanet J Rare Dis; 2022 Jan; 17(1):9. PubMed ID: 34991656
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of a patient-reported outcome measure specific for Gaucher disease with or without neurological symptoms in Japan.
Narita A; Koto Y; Noto S; Okada M; Ono M; Baba T; Sagara R; Sakai N
Orphanet J Rare Dis; 2024 Jan; 19(1):11. PubMed ID: 38183145
[TBL] [Abstract][Full Text] [Related]
4. Patient reported outcomes of patients with Gaucher disease type 1 treated with eliglustat in real-world settings: The ELIPRO study.
Camou F; Lagadec A; Coutinho A; Berger MG; Cador-Rousseau B; Gaches F; Belmatoug N
Mol Genet Metab; 2023 Nov; 140(3):107667. PubMed ID: 37597334
[TBL] [Abstract][Full Text] [Related]
5. The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry.
Rosenbloom B; Balwani M; Bronstein JM; Kolodny E; Sathe S; Gwosdow AR; Taylor JS; Cole JA; Zimran A; Weinreb NJ
Blood Cells Mol Dis; 2011 Jan; 46(1):95-102. PubMed ID: 21067946
[TBL] [Abstract][Full Text] [Related]
6. Patients with type 1 Gaucher disease in Spain: A cross-sectional evaluation of health status.
Giraldo P; Pérez-López J; Núñez R; de la Puebla RF; Luño E; Saura-Grau S; Bureo JC; Plaza S; de la Serna J
Blood Cells Mol Dis; 2016 Jan; 56(1):23-30. PubMed ID: 26603719
[TBL] [Abstract][Full Text] [Related]
7. Quality of life and psychological functioning of pediatric and young adult patients with Gaucher disease, type 1.
Alioto AG; Gomez R; Moses J; Paternostro J; Packman S; Packman W
Am J Med Genet A; 2020 May; 182(5):1130-1142. PubMed ID: 32125090
[TBL] [Abstract][Full Text] [Related]
8. Goal-oriented therapy with miglustat in Gaucher disease.
Pastores GM; Giraldo P; Chérin P; Mehta A
Curr Med Res Opin; 2009 Jan; 25(1):23-37. PubMed ID: 19210136
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry.
Khan A; Hangartner T; Weinreb NJ; Taylor JS; Mistry PK
J Bone Miner Res; 2012 Aug; 27(8):1839-48. PubMed ID: 22692814
[TBL] [Abstract][Full Text] [Related]
10. The influence of genetic variability and proinflammatory status on the development of bone disease in patients with Gaucher disease.
Gervas-Arruga J; Cebolla JJ; de Blas I; Roca M; Pocovi M; Giraldo P
PLoS One; 2015; 10(5):e0126153. PubMed ID: 25978039
[TBL] [Abstract][Full Text] [Related]
11. Acoustic radiation force impulse point shear wave elastography of the liver and spleen in patients with Gaucher disease type 1: Correlations with clinical data and markers of disease severity.
Lollert A; Hoffmann C; Lache M; König J; Brixius-Huth M; Hennermann JB; Düber C; Staatz G
Mol Genet Metab; 2020 Jun; 130(2):140-148. PubMed ID: 32245682
[TBL] [Abstract][Full Text] [Related]
12. [Quality of life of 22 patients with type 1 Gaucher disease after enzyme replacement therapy].
Li HM; Zhang RX; Long ZB; Du YL; Chen M; Zhuang JL; Qiu ZQ; Han B
Zhonghua Xue Ye Xue Za Zhi; 2020 Apr; 41(4):287-291. PubMed ID: 32447931
[No Abstract] [Full Text] [Related]
13. The International Collaborative Gaucher Group GRAF (Gaucher Risk Assessment for Fracture) score: a composite risk score for assessing adult fracture risk in imiglucerase-treated Gaucher disease type 1 patients.
Deegan P; Khan A; Camelo JS; Batista JL; Weinreb N
Orphanet J Rare Dis; 2021 Feb; 16(1):92. PubMed ID: 33602299
[TBL] [Abstract][Full Text] [Related]
14. Endocrine and metabolic disorders in patients with Gaucher disease type 1: a review.
Kałużna M; Trzeciak I; Ziemnicka K; Machaczka M; Ruchała M
Orphanet J Rare Dis; 2019 Dec; 14(1):275. PubMed ID: 31791361
[TBL] [Abstract][Full Text] [Related]
15. Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease.
Biegstraaten M; Cox TM; Belmatoug N; Berger MG; Collin-Histed T; Vom Dahl S; Di Rocco M; Fraga C; Giona F; Giraldo P; Hasanhodzic M; Hughes DA; Iversen PO; Kiewiet AI; Lukina E; Machaczka M; Marinakis T; Mengel E; Pastores GM; Plöckinger U; Rosenbaum H; Serratrice C; Symeonidis A; Szer J; Timmerman J; Tylki-Szymańska A; Weisz Hubshman M; Zafeiriou DI; Zimran A; Hollak CEM
Blood Cells Mol Dis; 2018 Feb; 68():203-208. PubMed ID: 28274788
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Bone Health in Patients With Type 1 Gaucher Disease Using Impact Microindentation.
Herrera S; Pérez-López J; Moltó-Abad M; Güerri-Fernández R; Cabezudo E; Novelli S; Esteve J; Hernández A; Roig I; Solanich X; Prieto-Alhambra D; Nogués X; Díez-Pérez A
J Bone Miner Res; 2017 Jul; 32(7):1575-1581. PubMed ID: 28263001
[TBL] [Abstract][Full Text] [Related]
17. Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher Disease.
Weill Y; Zimran A; Zadok D; Wasser LM; Revel-Vilk S; Hanhart J; Dinur T; Arkadir D; Becker-Cohen M
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987733
[TBL] [Abstract][Full Text] [Related]
18. A new framework for evaluating the health impacts of treatment for Gaucher disease type 1.
Ganz ML; Stern S; Ward A; Nalysnyk L; Selzer M; Hamed A; Weinreb N
Orphanet J Rare Dis; 2017 Feb; 12(1):38. PubMed ID: 28219443
[TBL] [Abstract][Full Text] [Related]
19. The Spectrum of Neurological and Sensory Abnormalities in Gaucher Disease Patients: A Multidisciplinary Study (SENOPRO).
Tullo MG; Cerulli Irelli E; Caramia F; Tessari G; Di Bonaventura C; Turchetta R; Giallonardo AT; Palumbo G; Bianchi S; Atturo F; Nebbioso M; Mancini P; Guariglia C; Giona F
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240189
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular diastolic dysfunction in type I Gaucher disease: an echo Doppler study.
Lo Iudice F; Barbato A; Muscariello R; Di Nardo C; de Stefano F; Sibilio M; Strazzullo P; de Simone G; Galderisi M
Echocardiography; 2015 Jun; 32(6):890-5. PubMed ID: 25250513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
